We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$7.48B
1-Year Est. Return
104.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.12%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.05B
AUM Growth
-$355M
(-5.5%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-3.93%
Top 10 Holdings %
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36
Avg Time Held
6.6
quarters
Top 10 Avg Time Held
3.6
quarters
Top 20 Avg Time Held
4.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GeneDx Holdings
WGS
|
+$41.9M |
| 2 |
Generac Holdings
GNRC
|
+$40.9M |
| 3 |
Vaxcyte
PCVX
|
+$24.8M |
| 4 |
Teradyne
TER
|
+$24.8M |
| 5 |
UL Solutions
ULS
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mirum Pharmaceuticals
MIRM
|
+$64.4M |
| 2 |
GE Vernova
GEV
|
+$42.1M |
| 3 |
Inspire Medical Systems
INSP
|
+$40.6M |
| 4 |
RNAM
Avidity Biosciences
RNAM
|
+$37.8M |
| 5 |
Lithia Motors
LAD
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.12% |
| 2 | Industrials | 19.41% |
| 3 | Technology | 15.63% |
| 4 | Energy | 7.14% |
| 5 | Consumer Discretionary | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Guardant Health
GH
$21.8B
| $218M | 3.61% |
2,362,379
-148,712
| -6% | -$14.9M |
2021 Q3
18 quarters
|
|
2
Trane Technologies
TT
$105B
| $169M | 2.8% |
406,555
+3,281
| +0.8% | +$1.39M |
2019 Q1
28 quarters
|
|
3
Lam Research
LRCX
$377B
| $147M | 2.42% |
688,402
+19,313
| +3% | +$4.32M |
2015 Q1
44 quarters
|
|
|
4
Mirum Pharmaceuticals
MIRM
$5.17B
| $130M | 2.15% |
1,408,871
-684,711
| -33% | -$64.4M |
2022 Q3
14 quarters
|
|
5
Targa Resources
TRGP
$62.8B
| $126M | 2.08% |
502,287
+21,737
| +5% | +$4.71M |
2022 Q1
16 quarters
|
|
6
Xometry
XMTR
$6.19B
| $121M | 2% |
2,960,239
+24,113
| +0.8% | +$1.28M |
2021 Q2
19 quarters
|
|
|
7
GE Vernova
GEV
$267B
| $116M | 1.91% |
133,200
-53,922
| -29% | -$42.1M |
2024 Q4
5 quarters
|
|
8
Old Dominion Freight Line
ODFL
$38B
| $115M | 1.91% |
591,691
-18,953
| -3% | -$3.53M |
2019 Q3
26 quarters
|
|
9
Scholar Rock
SRRK
$4.93B
| $108M | 1.78% |
2,197,385
-233,948
| -10% | -$10.5M |
2023 Q4
9 quarters
|
|
10
argenx
ARGX
$50.5B
| $91.7M | 1.52% |
125,657
+4,436
| +4% | +$3.47M |
2018 Q1
32 quarters
|
|
11
ASML
ASML
$660B
| $89.9M | 1.49% |
68,110
+1,290
| +2% | +$1.77M |
2013 Q4
49 quarters
|
|
12
iRhythm Holdings
IRTC
$3.55B
| $89.8M | 1.48% |
760,825
+68,339
| +10% | +$9.86M |
2022 Q2
15 quarters
|
|
13
Insmed
INSM
$21.1B
| $89.3M | 1.48% |
546,310
+62,721
| +13% | +$9.64M |
2022 Q4
13 quarters
|
|
14
Axsome Therapeutics
AXSM
$8.19B
| $87.8M | 1.45% |
519,558
-51,668
| -9% | -$8.92M |
2023 Q3
10 quarters
|
|
|
15
Vaxcyte
PCVX
$10.4B
| $79.8M | 1.32% |
1,374,292
+457,177
| +50% | +$24.8M |
2023 Q3
10 quarters
|
|
16
Entergy
ETR
$50.2B
| $76.5M | 1.27% |
682,847
+9,765
| +1% | +$982K |
2024 Q4
5 quarters
|
|
17
Vistra
VST
$54.5B
| $74M | 1.22% |
492,711
+5,075
| +1% | +$821K |
2023 Q3
10 quarters
|
|
18
United Rentals
URI
$66B
| $71.2M | 1.18% |
97,795
+1,855
| +2% | +$1.56M |
2025 Q1
4 quarters
|
|
19
Liberty Energy
LBRT
$3.12B
| $69.2M | 1.14% |
2,403,098
+432,639
| +22% | +$11M |
2025 Q4
1 quarter
|
|
20
Toast
TOST
$17.9B
| $66M | 1.09% |
2,488,669
+2,629
| +0.1% | +$78.5K |
2023 Q2
11 quarters
|
|
21
Mettler-Toledo International
MTD
$32B
| $64M | 1.06% |
50,751
+493
| +1% | +$665K |
2018 Q2
31 quarters
|
|
22
Monolithic Power Systems
MPWR
$64.8B
| $63.4M | 1.05% |
58,154
-10,219
| -15% | -$11.2M |
2020 Q3
22 quarters
|
|
23
Royalty Pharma
RPRX
$25.2B
| $62.6M | 1.04% |
1,312,534
+15,708
| +1% | +$688K |
2022 Q4
13 quarters
|
|
24
nVent Electric
NVT
$26.1B
| $61.6M | 1.02% |
523,557
+8,667
| +2% | +$984K |
2021 Q2
19 quarters
|
|
25
Williams Companies
WMB
$91.2B
| $60.5M | 1% |
832,248
+39,088
| +5% | +$2.71M |
2021 Q4
17 quarters
|
|
Similar funds
S
CCM
O
HI
HPC
FPP
RIG
TAM
Eventide Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Eventide Asset Management held 314 positions worth $6.05B, down 5.5% from $6.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Eventide Asset Management withdrew a net $238M in Q1 2026, closing 36 positions and reducing 70 holdings. Its most notable exit was Inspire Medical Systems, an estimated $40.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Industrials and Technology.
Against the trend, Eventide Asset Management opened a new position in GeneDx Holdings worth $29.5M.
- Eventide Asset Management's largest Q1 2026 buy was GeneDx Holdings: 459,015 shares worth $29.5M.
- Eventide Asset Management added most to Generac Holdings in Q1 2026, an estimated $40.9M increase.
- Eventide Asset Management's biggest Q1 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $64.4M.
- Eventide Asset Management fully exited Inspire Medical Systems in Q1 2026, selling an estimated $40.6M.
- Eventide Asset Management's ten largest holdings make up 22% of its $6.05B portfolio in Q1 2026.
- Eventide Asset Management opened 46 new positions and closed 36 in Q1 2026.
- Eventide Asset Management's portfolio value fell 5.5% quarter-over-quarter to $6.05B.
Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.